Research Coverage of Japanese Listed Companies, Shared Research Inc

Shared Research

Research Coverage of Japanese Listed Companies

Shared Research Inc

Pioneering research coverage of Japanese listed companies. Now customizable and interactive for global institutional investors. Corporate access reimagined.

Equity Bottom-Up

<ul><li>Revenue increased to JPY17.7bn (+5.2% YoY) due to subscriber growth in D2C and BPO services expansion.</li><li>Extraordinary losses included JPY829mn in impairment losses and JPY140mn for financial statement correction costs.</li><li>FY05/25 forecast: Revenue JPY21.0bn (+18.5% YoY), EBITDA JPY500mn, net loss JPY490mn to JPY290mn.</li></ul>

Revenue increased to JPY17.7bn (+5.2% YoY) due to subscriber growth in D2C and BPO services expansion.Extraordinary losses included JPY829mn in impairment losses and JPY140mn for financial statement correction costs.FY05/25 forecast: Revenue JPY21.0bn (+18.5% YoY), EBITDA JPY500mn, net loss JPY490mn to JPY290mn.

J Frontier Co Ltd (2934 JP): Full-year FY05/24 flash update

Japan

J Frontier Co., Ltd. offers health care services. The Company provides health care products sales, pharmaceutical mail order, medical platform development, dispensing pharmacies operation, and other services. J Frontier also operates health care marketing businesses.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

J Frontier Co Ltd (2934 JP): Full-year FY05/24 flash update

Revenue increased to JPY17.7bn (+5.2% YoY) due to subscriber growth in D2C and BPO services expansion. Extraordinary losses included JPY829mn in...

Shared Research